Platform, Underwrite Me, has added questions surrounding the use of weight loss treatment to its Protection Platform.
Questions are focused on the type of weight loss treatment as well as how long the treatment has been used and what the impact has been. The platform said these questions will allow insurers to make more accurate decisions for those seeking cover. UnderwriteMe said 2.5 million people in the UK are using Ozempic or Mounjaro for weight loss, the Protection Platform has seen 739 applicants disclose taking medical treatment to lose weight. Nilesh Patel, chief revenue and customer officer, UnderwriteMe, said: "Protection insurance is often highly dependent upon medical underwriting, and af...
To continue reading this article...
Join COVER for free
- Unlimited access to real-time news, key trend analysis and industry insights.
- Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
- Receive breaking news stories straight to your inbox in the daily newsletter.
- Members only access to monthly programme 'The COVER Review'
- Be the first to hear about our CPD accredited events and awards programmes.




